|
|
Artimplant Ab - Comparative Business Analysis Snapshot
Business Description
Artimplant Ab. The Group's principal activities are to develop, produce and market degradable implants that are designed to restore active lifestyles and improve quality of life. The Group focuses on identifying solutions to problems in orthopedic surgery and other areas of therapy. The Group has developed a number of different implants including products for reinforcing cruciate ligaments, treatment of arthritis of the thumb and a number of odontological indications. The Group's main product, the Artelon implant has contributed in restoration of thousands of patients who suffer from osteoarthritis and soft tissue injuries. The Group operates in the Nordic countries, the rest of Europe and the United States.
Competitor Analysis
This analysis compares Artimplant Ab with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
